Kevin Outterson
@koutterson.bsky.social
Working towards global ecological balance with bacteria. Married to Marya 38 years and counting. Professor at Boston University. All skeets my own.
The UN will soon unveil a new global science panel on #AMR - what can we do to make it effective and efficient? See the great papers from our conference in Lagos earlier this year: www.cgdev.org/project/buil...
Building the AMR Independent Panel: Lessons and Insights
A collaborative initiative to explore models, lessons, and frameworks to support the Independent Panel on Evidence for Action Against Antimicrobial Resistance
www.cgdev.org
October 28, 2025 at 7:29 PM
The UN will soon unveil a new global science panel on #AMR - what can we do to make it effective and efficient? See the great papers from our conference in Lagos earlier this year: www.cgdev.org/project/buil...
Are you a researcher working in infectious diseases or #AMR, from a social science discipline (broadly interpreted?). INAMRSS has 3 great opportunities for you!
www.globalstrategylab.org/events/open-...
Abstract submission open now - move fast!
www.globalstrategylab.org/events/open-...
Abstract submission open now - move fast!
Open Call for Social Science Presentations On Infectious Diseases - Global Strategy Lab
INAMRSS was founded to advance social science research on infectious diseases, including but not limited to antimicrobial resistance (AMR). In 2026, we are partnering with ESCMID Global (17-21 April i...
www.globalstrategylab.org
October 15, 2025 at 9:19 AM
Are you a researcher working in infectious diseases or #AMR, from a social science discipline (broadly interpreted?). INAMRSS has 3 great opportunities for you!
www.globalstrategylab.org/events/open-...
Abstract submission open now - move fast!
www.globalstrategylab.org/events/open-...
Abstract submission open now - move fast!
Issac Weldon from Univ Copenhagen describing what #AMR can learn from environmental governance www.youtube.com/watch?v=f4OS... based on our recent article w Kathleen Liddell (Univ Cambridge) in Milbank: pubmed.ncbi.nlm.nih.gov/40876865/
The Role of Environmental Governance in Tackling AMR
YouTube video by Global Strategy Lab
www.youtube.com
October 8, 2025 at 3:41 PM
Issac Weldon from Univ Copenhagen describing what #AMR can learn from environmental governance www.youtube.com/watch?v=f4OS... based on our recent article w Kathleen Liddell (Univ Cambridge) in Milbank: pubmed.ncbi.nlm.nih.gov/40876865/
The world needs better science to fight drug-resistant infections. #amr
www.cgdev.org/blog/amr-pan...
www.cgdev.org/blog/amr-pan...
The AMR Panel Playbook: Eight Lessons for Building an Independent Panel on Antimicrobial Resistance
Antimicrobial resistance (AMR) is one of the greatest health challenges of our time, responsible for 1.14 million deaths a year. Failure to keep resistance in check could lead to $1.7 trillion dollars...
www.cgdev.org
October 6, 2025 at 3:44 PM
The world needs better science to fight drug-resistant infections. #amr
www.cgdev.org/blog/amr-pan...
www.cgdev.org/blog/amr-pan...
How should the new Independent Panel on Evidence for Action on #AMR be set up? We gathered scientists and stakeholders - mainly from Africa - to think this through in Lagos, Nigeria. Pre-print now available:
verixiv.org/articles/2-2...
verixiv.org/articles/2-2...
verixiv.org
September 10, 2025 at 2:02 PM
How should the new Independent Panel on Evidence for Action on #AMR be set up? We gathered scientists and stakeholders - mainly from Africa - to think this through in Lagos, Nigeria. Pre-print now available:
verixiv.org/articles/2-2...
verixiv.org/articles/2-2...
New funding opportunity opened today for Gram-negative antibacterial discovery (as late as LO) in therapeutics! gcgh.grandchallenges.org/challenge/in...
Innovations for Gram-Negative Antibiotic Discovery
Innovations for Gram-Negative Antibiotic Discovery Grand Challenges RFP
gcgh.grandchallenges.org
February 11, 2025 at 10:13 PM
New funding opportunity opened today for Gram-negative antibacterial discovery (as late as LO) in therapeutics! gcgh.grandchallenges.org/challenge/in...
Welcome
Looking forward to a $🚀-free, Orange-free experience on Bluesky 🙂
#AMR #InfectiousDiseases #vaccination #WASH #Pandemics #GlobalHealth #Health
#AMR #InfectiousDiseases #vaccination #WASH #Pandemics #GlobalHealth #Health
February 9, 2025 at 7:16 PM
Welcome
This law student note presumes that important zoonotic jumps from animals to humans occur in the USA, leading to a recommendation to more tightly regulate live animal importation. For most salient examples, such as COVID and HIV/AIDS, zoonotic transmission was outside the USA.
The Harvard Law Review on "The Import of Zoonotic Diseases" in the US.
A timely review as climate and environmental changes, extractive and agricultural industries, and increasing human mobility heighten our risk of exposure to zoonotic infections.
harvardlawreview.org/print/vol-13...
A timely review as climate and environmental changes, extractive and agricultural industries, and increasing human mobility heighten our risk of exposure to zoonotic infections.
harvardlawreview.org/print/vol-13...
The Import of Zoonotic Diseases
Introduction In 2020, “zoonosis”Zoonoses are “any disease or infection that is naturally transmissible from vertebrate animals to humans.” Zoonoses, WHO (July 29, 2020), https:/
harvardlawreview.org
January 24, 2025 at 11:00 AM
This law student note presumes that important zoonotic jumps from animals to humans occur in the USA, leading to a recommendation to more tightly regulate live animal importation. For most salient examples, such as COVID and HIV/AIDS, zoonotic transmission was outside the USA.
Which lessons can be learned from prior international science panels? How can this help the new Independent Panel on Evidence for Action on AMR? www.cgdev.org/blog/chartin...
Charting the Path to Tackle AMR: How to Create an Inclusive and Impactful Independent Panel
In 2021 alone, AMR killed an estimated 1.14 million people annually—and if countries stick to a business-as-usual approach, it could claim 39 million lives between 2025 and 2050. Beyond the human toll...
www.cgdev.org
January 22, 2025 at 3:33 PM
Which lessons can be learned from prior international science panels? How can this help the new Independent Panel on Evidence for Action on AMR? www.cgdev.org/blog/chartin...
@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.
January 16, 2025 at 11:53 AM
@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.
@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.
January 16, 2025 at 11:31 AM
@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.
Dr Sonia Lewycka on equity discourse in AMR. Most AMR deaths are in lower income settings, so solutions must center equity. (Un)intended Consequences conf @ British Academy.
January 15, 2025 at 2:22 PM
Dr Sonia Lewycka on equity discourse in AMR. Most AMR deaths are in lower income settings, so solutions must center equity. (Un)intended Consequences conf @ British Academy.
Nice way to transform Reviewer 2 comments into a paper!
While writing papers and grants, we received many comments on the role of CNVs in antifungal resistance. We thought we should formally assess how important they are. Here is what we found. #AMR #fungi #evolution rdcu.be/d5rbN
The role of gene copy number variation in antimicrobial resistance in human fungal pathogens
npj Antimicrobials and Resistance - The role of gene copy number variation in antimicrobial resistance in human fungal pathogens
www.nature.com
January 9, 2025 at 3:15 PM
Nice way to transform Reviewer 2 comments into a paper!
I also have concerns about the equities of this system
My main concerns relate to the question of age of retirement. I have thought about a 5 year rolling contract system whereby a faculty member would have 5 years of job security as long as they were performing at a reasonable level. This addresses the problem of truly non-contributory senior faculty.
December 19, 2024 at 9:47 PM
I also have concerns about the equities of this system
Academic Twitter found a new home. More Bluetorials, please. Any regrets from how the tenure system operates?
Bluetorial: Adventures with tenure-Part 2
My experiences on the Johns Hopkins School of Medicine Professorial Promotions Committee with some thoughts about scholarship vs fund raising success, team science, hyperproductivity, and the age distribution of the professoriate.
My experiences on the Johns Hopkins School of Medicine Professorial Promotions Committee with some thoughts about scholarship vs fund raising success, team science, hyperproductivity, and the age distribution of the professoriate.
a cartoon says hey everybody an old man 's talking while bart simpson looks on
ALT: a cartoon says hey everybody an old man 's talking while bart simpson looks on
media.tenor.com
December 19, 2024 at 3:03 PM
Academic Twitter found a new home. More Bluetorials, please. Any regrets from how the tenure system operates?
Do we have an AMR group?
Hey #AMR and #MicroSky people, @bonniehyatt.bsky.social is here! Bonnie is a great PhD student at @thekidsau.bsky.social with @tbarnett.bsky.social, and recently won a WCVID seed grant to investigate the microbiome-dependent antibiotic resistance in Strep A.
December 17, 2024 at 12:55 PM
Do we have an AMR group?
Access to essential medicines is not improving over the past 4 decades with existing tools.
"The gap between richer (high- and upper-middle-income) and poorer (lower-middle- and low-income) countries remained largely unchanged over time."
www.healthaffairs.org/doi/epdf/10....
"The gap between richer (high- and upper-middle-income) and poorer (lower-middle- and low-income) countries remained largely unchanged over time."
www.healthaffairs.org/doi/epdf/10....
December 9, 2024 at 2:55 PM
Access to essential medicines is not improving over the past 4 decades with existing tools.
"The gap between richer (high- and upper-middle-income) and poorer (lower-middle- and low-income) countries remained largely unchanged over time."
www.healthaffairs.org/doi/epdf/10....
"The gap between richer (high- and upper-middle-income) and poorer (lower-middle- and low-income) countries remained largely unchanged over time."
www.healthaffairs.org/doi/epdf/10....
Most cervical cancer deaths are in lower-income settings worldwide; rollout of the vaccines there has been painfully slower than high-income countries. Bring this good thing to more people.
HPV vaccines work.
HPV vaccine impact hitting milestone: US cervical cancer deaths among women under 25 have plummeted since 2016, far exceeding projected trends. Prevention works, vaccines save lives.
December 9, 2024 at 2:26 PM
Most cervical cancer deaths are in lower-income settings worldwide; rollout of the vaccines there has been painfully slower than high-income countries. Bring this good thing to more people.
15 years data on infections from the US VA: www.thelancet.com/journals/lan...
My 3 takeaways: (1) Infection prevention and control works; (2) We still need better antibiotics; and (3) the choice of the denominator in such studies should be carefully made
www.thelancet.com/journals/lan...
My 3 takeaways: (1) Infection prevention and control works; (2) We still need better antibiotics; and (3) the choice of the denominator in such studies should be carefully made
www.thelancet.com/journals/lan...
Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)
Significant reductions in methicillin resistance in S aureus, vancomycin-resistant E faecium, and fluoroquinolone resistance across multiple pathogens suggest that control efforts have had an effect on resistance. The rise in extended-spectrum β-lactamases-producing Enterobacterales and recent surge in hospital-associated infections emphasise the need for ongoing surveillance and interventions. Our study highlights how coupling the analysis of phenotypic incidence with resistance proportion can enhance interpretation of antimicrobial resistance data.
www.thelancet.com
December 9, 2024 at 2:23 PM
15 years data on infections from the US VA: www.thelancet.com/journals/lan...
My 3 takeaways: (1) Infection prevention and control works; (2) We still need better antibiotics; and (3) the choice of the denominator in such studies should be carefully made
www.thelancet.com/journals/lan...
My 3 takeaways: (1) Infection prevention and control works; (2) We still need better antibiotics; and (3) the choice of the denominator in such studies should be carefully made
www.thelancet.com/journals/lan...
Bacteria adapt to take advantage of human weaknesses and situations, including war. We should not be surprised that the bacteria rule the battlefield. www.nytimes.com/2024/11/26/m...
Modern Warfare Is Breeding Deadly Superbugs. Why?
Researchers are trying to understand why resistant pathogens are so prevalent in the war-torn nations of the Middle East.
www.nytimes.com
December 7, 2024 at 11:05 PM
Bacteria adapt to take advantage of human weaknesses and situations, including war. We should not be surprised that the bacteria rule the battlefield. www.nytimes.com/2024/11/26/m...
Research is of limited use unless communicated - thanks for this 1 pager
December 5, 2024 at 1:53 PM
Research is of limited use unless communicated - thanks for this 1 pager
Analysis like this systematic review from 5 years ago is needed to move AMR policy forward in the era of an Independent Panel on Evidence For Action on AMR. #IPEA-AMR Here, a careful critique of methodology choices in studies reporting the economic costs of AMR. link.springer.com/article/10.1...
Using the best available data to estimate the cost of antimicrobial resistance: a systematic review - Antimicrobial Resistance & Infection Control
Background Valuation of the economic cost of antimicrobial resistance (AMR) is important for decision making and should be estimated accurately. Highly variable or erroneous estimates may alarm policy...
link.springer.com
December 4, 2024 at 12:27 AM
Analysis like this systematic review from 5 years ago is needed to move AMR policy forward in the era of an Independent Panel on Evidence For Action on AMR. #IPEA-AMR Here, a careful critique of methodology choices in studies reporting the economic costs of AMR. link.springer.com/article/10.1...
When azithromycin is overused in high-income countries, no one tries to stop life-saving treatments. 1/2 www.nejm.org/doi/full/10....
Azithromycin to Reduce Mortality | NEJM
To the Editor: The AVENIR (Azithromycine pour la Vie des Enfants au Niger: Implementation
et Recherche) trial reported by O’Brien et al. (Aug. 22/29 issue)1 shows the mortality
benefit of mass dist...
www.nejm.org
December 1, 2024 at 7:56 PM
When azithromycin is overused in high-income countries, no one tries to stop life-saving treatments. 1/2 www.nejm.org/doi/full/10....
In 3 large hospitals in Chile, a retrospective analysis of patients with blood stream infections found around a third of patients received inappropriate empiric antibacterial therapy, with higher in-hospital mortality and costs. bmjpublichealth.bmj.com/content/2/2/...
Impact of inappropriate empirical antibiotic therapy on in-hospital mortality: a retrospective multicentre cohort study of patients with bloodstream infections in Chile, 2018–2022
Introduction Empirical antibiotic therapy is essential for treating bloodstream infections (BSI), yet there is limited evidence from resource-limited settings. We quantified the association of inappro...
bmjpublichealth.bmj.com
December 1, 2024 at 7:47 PM
In 3 large hospitals in Chile, a retrospective analysis of patients with blood stream infections found around a third of patients received inappropriate empiric antibacterial therapy, with higher in-hospital mortality and costs. bmjpublichealth.bmj.com/content/2/2/...